Testing Report

Retesting GHK-Cu: following up on last cycle's discrepancies

4 independently tested samples across 4 companies, and what the results say about GHK-Cu.

Retesting GHK-Cu: following up on last cycle's discrepancies

GHK-Cu is a naturally occurring copper-binding tripeptide with a development status of "cosmetic use / preclinical". The Institute rates the strength of its published evidence as moderate. A copper-binding tripeptide found in human plasma, extensively studied in skin-repair and cosmetic contexts.

This report covers the GHK-Cu samples processed in our most recent testing cycle. Every specimen was purchased anonymously at retail, transferred under chain-of-custody documentation, and analysed by an independent contract laboratory.

The Institute has independently tested 4 GHK-Cu samples from 4 companies. 75% met their label claims on purity and content. Measured purity ranged from 69.1% to 98.8%, averaging 90.7%. 1 sample failed verification outright. Every specimen is published in full, including the laboratory that ran it.

The Peptide Institute is an independent research institute. We do not sell products, we do not accept vendor sponsorship, and we publish results that reflect badly on companies as readily as results that do not.

Free download

Get the free Peptide Playbook, plus new breakthroughs as they happen.

What peptides are, why people are using them, and what results people are talking about, in plain English. Sign up and we email you the Playbook right away.

Free. Unsubscribe anytime.

  • The Peptide Playbook, free in your inbox
  • Occasional updates on new developments
  • No spam, unsubscribe anytime